Dr Lal PathLabs share price surged up to 20% to hit upper circuit after Q4FY26 results, with revenue rising 16.6% YoY and ...
April 25 (Reuters) - Dr Lal Path Labs (DLPA.NS), opens new tab, India's largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its ...
(Refiles to remove extraneous link in paragraph 1) April 30 (Reuters) - Dr Lal Path Labs reported a 15.5% drop in fourth-quarter profit on Thursday, hurt by higher tax expenses. Here are some details: ...
Bengaluru: Dr. Lal Path Labs reported a lower third-quarter profit on Friday after taking a one-time charge linked to India's new labour code, despite strong demand for its bundled test packages.
Diagnostics major Dr. Lal Path Labs saw revenue improve 17% year-on-year to ₹703 crore in the March quarter (Q4FY26), beating consensus estimate by 5%. The jump was primarily led by higher sample ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results